Cyclosporine A to Treat Unexplained Recurrent Spontaneous Abortions: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial

BACKGROUND: The World Health Organization (WHO) has defined Unexplained Recurrent Spontaneous Abortion (URSA) as three and more consecutive miscarriages before the 20th week of gestation. To date, empiric therapy for patients with unexplained recurrent pregnancy loss (URPL) is not precise. Studies h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nan, Ge, Hongshan, Zhou, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670855/
https://www.ncbi.nlm.nih.gov/pubmed/34916855
http://dx.doi.org/10.2147/IJWH.S330921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670855/
https://www.ncbi.nlm.nih.gov/pubmed/34916855
http://dx.doi.org/10.2147/IJWH.S330921

Ejemplares similares